Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01399489 · ClinicalTrials.gov registry record · NA
Aerobic Training and Arterial Stiffness in Chronic Kidney Disease (CKD) Patients
A NA study, sponsored by Springfield College.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT01399489: Completed NA study, sponsored by Springfield College.
NCT01399489 is a NA study that has completed, run by Springfield College. The registered enrollment target is 51 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01399489, a NA study, has completed, sponsored by Springfield College.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The current study is designed to examine the impact of 16 weeks of moderate intensity aerobic training on arterial stiffness and blood pressure in stage 3 chronic kidney disease (CKD) patients. The investigators hypothesize that short term aerobic training will improve the stiffness of arteries in CKD patients.
Primary Outcome
Arterial stiffness is measured via pulse wave velocity. In addition augmentation index is also being assessed. Blood pressure is being measured under resting conditions and via 24 hr ambulatory devices.
Interventions
- BEHAVIORAL Exercise training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-12 |
| Phase | NA |
What the finished NCT01399489 record still lists
NCT01399489 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Exercise training is the first listed.
NCT01399489 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01399489 about?
NCT01399489 is a clinical study titled "Aerobic Training and Arterial Stiffness in Chronic Kidney Disease (CKD) Patients". The current study is designed to examine the impact of 16 weeks of moderate intensity aerobic training on arterial stiffness and blood pressure in stage 3 chronic kidney disease (CKD) patients. The investigators hypothesize that short term aerobic training will improve the stiffness of arteries in C...
What is the current status of trial NCT01399489?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2009-09. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01399489?
The interventions under investigation include: Exercise training (BEHAVIORAL).
Who is sponsoring clinical trial NCT01399489?
This trial is sponsored by Springfield College, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01399489's enrollment target sits among peer trials
51 1279th of 2000 higher than 722 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia